Techcyte expands digital pathology platform
Techcyte has added anatomic pathology to its Fusion digital pathology platform, creating an open, standards-based software-as-a-service offering that unifies clinical and anatomic pathology workflows.
Fusion’s open-architecture design allows laboratories to integrate third-party AI solutions into Techcyte’s proprietary AI.
In a separate announcement, Techcyte reported plans to integrate Aiforia’s artificial intelligence-powered diagnostic algorithms into Fusion’s pathology workflow.
Techcyte initially will integrate Aiforia’s breast cancer diagnostic algorithms into the Fusion anatomic pathology laboratory workflow. The company plans to eventually expand its working relationship with Aiforia to other areas.
“Through this non-exclusive collaboration, Techcyte and Aiforia are jointly working to deliver fully integrated, AI-powered digital pathology workflows to laboratories worldwide,” according to a Techcyte press statement.
Fusion is available for research use only in the United States. It is CE-IVDD marked for in vitro diagnostic use in the European Union.
Techcyte, 888-878-3249
Oxford Nanopore Technologies and Cepheid developing sequencing-based solutions
Oxford Nanopore Technologies and Cepheid are collaborating to create and commercialize an end-to-end workflow that combines Cepheid’s GeneXpert system for pre-sequencing sample and library preparation with Oxford’s molecular-analysis platform.
“The two companies have completed a successful proof-of-concept study which demonstrated the feasibility of using Cepheid’s cartridge-based GeneXpert system for sample and library preparation in a workflow with Oxford Nanopore’s sequencing platform,” according to a joint press release from the companies.
The workflow is intended to allow customers to perform sequencing in-house for infectious disease analysis, returning results within hours.
The companies are specifically focusing on delivering a scalable, automated, end-to-end solution for simplified nanopore-sequencing workflows that can be used by a variety of laboratories, including those that have not had the expertise to conduct sequencing.
The solution will be available for research use only.
Cepheid, 888-838-3222
Dr. Aller practices clinical informatics in Southern California. He can be reached at rayaller@gmail.com. Dennis Winsten is founder of Dennis Winsten & Associates, Healthcare Systems Consultants. He can be reached at dennis.winsten@gmail.com.